Mindmed

Mindmed is the leading neuro-pharmaceutical company which discovers, develops and deploys psychedelic inspired medicines.  The company’s immediate priority is to address the opioid crisis and other forms of addiction by developing its lead drug candidate 18-MC based on the psychedelic substance ibogaine.